BALYASNY ASSET MANAGEMENT L.P. - PEAR THERAPEUTICS INC ownership

PEAR THERAPEUTICS INC's ticker is and the CUSIP is 704723113. A total of 36 filers reported holding PEAR THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of PEAR THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$2,766
-87.6%
145,600
-2.9%
0.00%
Q4 2022$22,335
-10.7%
150,0000.0%0.00%
Q3 2022$25,000
+8.7%
150,0000.0%0.00%
Q2 2022$23,000
-80.7%
150,0000.0%0.00%
Q1 2022$119,000
+32.2%
150,0000.0%0.00%
Q4 2021$90,000150,0000.00%
Other shareholders
PEAR THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Kingstown Capital 385,000$231,0000.29%
Integrity Capital Management (HK) Ltd 50,333$30,0000.10%
Arena Investors LP 126,122$75,686,0000.08%
Telemetry Investments, L.L.C. 85,502$51,0000.07%
DIFESA CAPITAL MANAGEMENT, LP 150,000$90,0000.06%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 1,796,251$1,078,0000.02%
Silver Rock Financial LP 188,505$113,0000.02%
ANGELO GORDON & CO., L.P. 33,332$207,0000.02%
Owl Creek Asset Management, L.P. 414,000$248,0000.02%
P SCHOENFELD ASSET MANAGEMENT LP 477,602$287,0000.01%
View complete list of PEAR THERAPEUTICS INC shareholders